Please login to the form below

uterine fibroids

This page shows the latest uterine fibroids news and features for those working in and with pharma, biotech and healthcare.

Bayer extends alliance with Evotec in women’s health

The lead candidate from the endometriosis alliance is vilaprisan, which has advanced into phase 2 trials in both endometriosis and uterine fibroids but suffered a setback at the end of 2018,

Latest news

Myovant preps US filing for relugolix in prostate cancer

Myovant is in a head-to-head battle with AbbVie and its rival GnRH inhibitor Orilissa (elagolix) in endometriosis-related pain and uterine fibroids, but has a clear run at the ... cancer”. It’s also an important development as Myovant has delayed
AbbVie files blockbuster hopeful elagolix for uterine fibroids

Will face competition from Myovant rival. AbbVie is gunning for the second indication for its new women’s health product Orilissa, hoping to add uterine fibroids to its FDA approval last ... That raises the question of whether women will be prepared to
Myovant has second phase 3 trial to back its uterine fibroids drug

and was due to be filed for the uterine fibroids indication right about now, giving it a few months’ head start. ... Analysts suggest that uterine fibroids could be a $1bn-plus market for GnRH antagonists.
Myovant’s fibroids drug clears phase 3 trial, but shares sink

Uterine fibroids are non-cancerous tumours that form in the muscle walls of the uterus and affect between 20% and 80% of women by the age of 50. ... Their drug is already approved as Orilissa to treat endometriosis and has two positive phase 3 readouts
Urovant slips on phase 3 incontinence drug data

Others cued up for results include phase 3 trials of Myovant’s relugolix in uterine fibroids, endometriosis and prostate cancer, and Dermavant’s tapinarof in psoriasis.

More from news
Approximately 5 fully matching, plus 23 partially matching documents found.

Latest from PMHub

July 2020: diversity and inclusion in clinical trials round-up

Dr. Charlotte Owens, an OB-GYN and medical director of AbbVie, has completed successful clinical trials on uterine fibroids with a high representation of Black women, and outlines the key steps

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company

Iguazu

Iguazu Ltd is a digital healthcare agency, delivering tactical and innovative solutions. WHAT WE DO We are Closed Loop Marketing...

Latest intelligence

Surviving cancer: a new era for patients: Now more than ever, a shift in perspective is needed...
Crisis? No problem!: Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?: First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....